• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咳嗽反射高敏作为一个关键的可治疗特征。

Cough Reflex Hypersensitivity as a Key Treatable Trait.

作者信息

Song Woo-Jung, Manian Deepti Vellaichamy, Kim Yeonhee, Zhang Mengru, Morice Alyn H

机构信息

Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Division of Allergy and Immunology, Stormont Vail Health, Topeka, Kan.

出版信息

J Allergy Clin Immunol Pract. 2025 Mar;13(3):469-478. doi: 10.1016/j.jaip.2024.10.046. Epub 2024 Nov 16.

DOI:10.1016/j.jaip.2024.10.046
PMID:39557291
Abstract

Cough reflex hypersensitivity is emerging as a key treatable trait in chronic cough and other cough-associated respiratory conditions. This review examines the neurological basis of cough, highlighting the complex interplay between peripheral and central mechanisms. The concept of cough hypersensitivity aims to address unmet clinical needs by recognizing chronic cough as a distinct disorder rather than merely a symptom. Evidence from clinical trials supports cough hypersensitivity as a treatable trait in chronic cough, with opiates, gabapentinoids, and novel P2X3 antagonists showing efficacy. Cough hypersensitivity is also relevant in conditions presenting with persistent cough, such as asthma, bronchiectasis, and idiopathic pulmonary fibrosis, though more research is needed. Recognizing cough reflex hypersensitivity as a treatable trait offers new avenues for management, particularly for patients with persistent cough despite etiology-targeted therapies. We propose redefining chronic cough as a distinct disease entity in which cough hypersensitivity is a common feature and key therapeutic target, potentially leading to better patient care and the development of novel therapies.

摘要

咳嗽反射超敏反应正逐渐成为慢性咳嗽及其他与咳嗽相关的呼吸道疾病中一个关键的可治疗特征。本综述探讨了咳嗽的神经学基础,强调了外周和中枢机制之间复杂的相互作用。咳嗽超敏反应的概念旨在通过将慢性咳嗽视为一种独特的疾病而非仅仅是一种症状,来满足未被满足的临床需求。临床试验证据支持咳嗽超敏反应作为慢性咳嗽的一种可治疗特征,阿片类药物、加巴喷丁类药物和新型P2X3拮抗剂已显示出疗效。咳嗽超敏反应在伴有持续性咳嗽的疾病中也具有相关性,如哮喘、支气管扩张和特发性肺纤维化,不过仍需要更多研究。将咳嗽反射超敏反应视为一种可治疗特征为管理提供了新途径,特别是对于那些尽管接受了针对病因的治疗仍有持续性咳嗽的患者。我们建议将慢性咳嗽重新定义为一种独特的疾病实体,其中咳嗽超敏反应是一个共同特征和关键治疗靶点,这可能会带来更好的患者护理并推动新型疗法的开发。

相似文献

1
Cough Reflex Hypersensitivity as a Key Treatable Trait.咳嗽反射高敏作为一个关键的可治疗特征。
J Allergy Clin Immunol Pract. 2025 Mar;13(3):469-478. doi: 10.1016/j.jaip.2024.10.046. Epub 2024 Nov 16.
2
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough.P2X3 受体拮抗剂作为潜在的镇咳药:慢性咳嗽的当前临床试验总结。
Lung. 2020 Aug;198(4):609-616. doi: 10.1007/s00408-020-00377-8. Epub 2020 Jul 13.
3
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.P2X3 受体拮抗剂(AF-219)治疗难治性慢性咳嗽:一项随机、双盲、安慰剂对照的 2 期研究。
Lancet. 2015 Mar 28;385(9974):1198-205. doi: 10.1016/S0140-6736(14)61255-1. Epub 2014 Nov 25.
4
Advances in mechanisms and management of chronic cough: The Ninth London International Cough Symposium 2016.慢性咳嗽机制和管理的进展:2016 年第九届伦敦国际咳嗽研讨会。
Pulm Pharmacol Ther. 2017 Dec;47:2-8. doi: 10.1016/j.pupt.2017.02.003. Epub 2017 Feb 16.
5
P2X3 receptor antagonist in chronic cough.慢性咳嗽中的P2X3受体拮抗剂
Lancet. 2015 Jul 18;386(9990):244. doi: 10.1016/S0140-6736(15)61274-0.
6
Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.外周机制II:外周活性镇咳药的药理学
Handb Exp Pharmacol. 2009;187(187):155-86. doi: 10.1007/978-3-540-79842-2_8.
7
P2X3 receptor antagonist in chronic cough--Authors' reply.慢性咳嗽中的P2X3受体拮抗剂——作者回复
Lancet. 2015 Jul 18;386(9990):244-5. doi: 10.1016/S0140-6736(15)61275-2.
8
Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.治疗难治性慢性咳嗽的 P2X3 受体拮抗剂 gefapixant 的临床开发进展。
Pulm Pharmacol Ther. 2019 Jun;56:75-78. doi: 10.1016/j.pupt.2019.03.006. Epub 2019 Mar 14.
9
The pharmacology of cough.咳嗽的药理学
Trends Pharmacol Sci. 2004 Nov;25(11):569-76. doi: 10.1016/j.tips.2004.09.009.
10
The Clinical Approach to Chronic Cough.慢性咳嗽的临床处理方法
J Allergy Clin Immunol Pract. 2025 Mar;13(3):454-466. doi: 10.1016/j.jaip.2024.11.004. Epub 2024 Nov 16.

引用本文的文献

1
Treatable traits in chronic cough: a prospective evaluation for predicting cough persistence.慢性咳嗽的可治疗特征:预测咳嗽持续时间的前瞻性评估
ERJ Open Res. 2025 Aug 26;11(4). doi: 10.1183/23120541.01357-2024. eCollection 2025 Jul.
2
Association of throat sensation severity with quality of life in patients with chronic cough.慢性咳嗽患者咽喉部感觉严重程度与生活质量的相关性
J Thorac Dis. 2025 Jul 31;17(7):4672-4680. doi: 10.21037/jtd-2024-1994. Epub 2025 Jul 25.
3
ICD-10 Diagnostic Coding Patterns and Clinical Correlates in Refractory Chronic Cough: Analysis from the Korean Chronic Cough Registry.
难治性慢性咳嗽的ICD-10诊断编码模式及临床关联:来自韩国慢性咳嗽登记处的分析
Lung. 2025 Jul 20;203(1):81. doi: 10.1007/s00408-025-00836-0.
4
Disease finds its identity with treatment in the real world: the use of gefapixant in chronic cough.疾病在现实世界中的治疗中得以明确:格帕沙星在慢性咳嗽中的应用。
ERJ Open Res. 2025 Jul 7;11(4). doi: 10.1183/23120541.00096-2025. eCollection 2025 Jul.
5
How Will a Treatable Traits Approach Reshape Clinical Practice in Chronic Cough?可治疗特征方法将如何重塑慢性咳嗽的临床实践?
Allergy Asthma Immunol Res. 2025 May;17(3):304-316. doi: 10.4168/aair.2025.17.3.304.
6
Efficacy and Safety of Fexuprazan Versus Esomeprazole for Gastroesophageal Reflux Disease-Related Chronic Cough: A Randomized, Double-Blind, Active-Controlled Exploratory Trial.非布司他与埃索美拉唑治疗胃食管反流病相关慢性咳嗽的疗效和安全性:一项随机、双盲、活性对照探索性试验。
Lung. 2025 Apr 29;203(1):59. doi: 10.1007/s00408-025-00815-5.
7
Cough and dyspnea management in pulmonary fibrosis.肺纤维化中咳嗽与呼吸困难的管理
Curr Opin Support Palliat Care. 2025 Jun 1;19(2):103-110. doi: 10.1097/SPC.0000000000000753. Epub 2025 Mar 25.